Skip Nav Destination
Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy
Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism
Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia
Issue Archive
July 1 2001
Table of Contents
INSIDE BLOOD
FOCUS ON HEMATOLOGY
Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region–derived stromal cells
Sahoko Matsuoka,Kohichiro Tsuji,Hiroaki Hisakawa,Ming-jiang Xu,Yasuhiro Ebihara,Takefumi Ishii,Daisuke Sugiyama,Atsushi Manabe,Ryuhei Tanaka,Yasuo Ikeda,Shigetaka Asano,Tatsutoshi Nakahata
PLENARY PAPERS
PERSPECTIVE
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients
Clinical Trials & Observations
Neil E. Kay,Tracy L. Leong,Nancy Bone,David H. Vesole,Philip R. Greipp,Brian Van Ness,Martin M. Oken,Robert A. Kyle
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy
Clinical Trials & Observations
Andy C. Rawstron,Ben Kennedy,Paul A. S. Evans,Faith E. Davies,Stephen J. Richards,Andy P. Haynes,Nigel H. Russell,Geoff Hale,Gareth J. Morgan,Andrew S. Jack,Peter Hillmen
Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)
Clinical Trials & Observations
Madhav V. Dhodapkar,Joth L. Jacobson,Morie A. Gertz,Saul E. Rivkin,G. David Roodman,Joseph M. Tuscano,Muhammad Shurafa,Robert A. Kyle,John J. Crowley,Bart Barlogie
GENE THERAPY
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells
Viggo F. I. Van Tendeloo,Peter Ponsaerts,Filip Lardon,Griet Nijs,Marc Lenjou,Christine Van Broeckhoven,Dirk R. Van Bockstaele,Zwi N. Berneman
HEMATOPOIESIS
Rescue of the colony-stimulating factor 1 (CSF-1)–nullizygous mouse (Csf1op/Csf1op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis
Gregory R. Ryan,Xu-Ming Dai,Melissa G. Dominguez,Wei Tong,Fenchi Chuan,Orin Chisholm,Robert G. Russell,Jeffrey W. Pollard,E. Richard Stanley
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin: Presented in part at the 42nd Annual Meeting of the American Society of Hematology, December 1-5, 2000, San Francisco, CA.
Paola Piccardoni,Rita Sideri,Stefano Manarini,Antonio Piccoli,Nicola Martelli,Giovanni de Gaetano,Chiara Cerletti,Virgilio Evangelista
IMMUNOBIOLOGY
Dysfunctional Epstein-Barr virus (EBV)–specific CD8+T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma
Debbie van Baarle,Egbert Hovenkamp,Margareth F. C. Callan,Katja C. Wolthers,Stefan Kostense,Linda C. Tan,Hubert G. M. Niesters,Albert D. M. E. Osterhaus,Andrew J. McMichael,Marinus H. J. van Oers,Frank Miedema
NEOPLASIA
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis
Stephen E. Straus,Elaine S. Jaffe,Jennifer M. Puck,Janet K. Dale,Keith B. Elkon,Angela Rösen-Wolff,Anke M. J. Peters,Michael C. Sneller,Claire W. Hallahan,Jin Wang,Roxanne E. Fischer,Christine M. Jackson,Albert Y. Lin,Caroline Bäumler,Elke Siegert,Alexander Marx,Akshay K. Vaishnaw,Tamara Grodzicky,Thomas A. Fleisher,Michael J. Lenardo
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
Faith E. Davies,Noopur Raje,Teru Hideshima,Suzanne Lentzsch,Gloria Young,Yu-Tzu Tai,Boris Lin,Klaus Podar,Deepak Gupta,Dharminder Chauhan,Steven P. Treon,Paul G. Richardson,Robert L. Schlossman,Gareth J. Morgan,George W. Muller,David I. Stirling,Kenneth C. Anderson
TRANSPLANTATION
Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers
Marcelo de Carvalho Bittencourt,Sylvain Perruche,Emmanuel Contassot,Stéphanie Fresnay,Marie-Hélène Baron,Régis Angonin,François Aubin,Patrick Hervé,Pierre Tiberghien,Philippe Saas
BRIEF REPORTS
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism
Brief Report
Cornelia M. Ulrich,Yutaka Yasui,Rainer Storb,Mark M. Schubert,John L. Wagner,Jeannette Bigler,Kiley S. Ariail,Cassie L. Keener,Sue Li,Hao Liu,Federico M. Farin,John D. Potter
Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia
Brief Report
Rolf M. Mesters,Teresa Padró,Ralf Bieker,Martin Steins,Michael Kreuter,Michael Göner,Stephen Kelsey,Paul Scigalla,Walter Fiedler,Thomas Büchner,Wolfgang E. Berdel
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals